Wu KY, Wang XC, Anderson M, Tran SD. Innovative use of nanomaterials in treating retinopathy of prematurity. Pharmaceuticals (Basel, Switzerland). 2024. https://doi.org/10.3390/ph17101377.

Article  PubMed  PubMed Central  Google Scholar 

Sjöbom U, Hellqvist T, Humayun J, et al. Circulating VEGF-A levels in relation to retinopathy of prematurity and treatment effects: a systematic review and meta-analysis. Ophthalmol Sci. 2024;4(6): 100548. https://doi.org/10.1016/j.xops.2024.100548.

Article  PubMed  PubMed Central  Google Scholar 

Fielder A, Blencowe H, O’Connor A, Gilbert C. Impact of retinopathy of prematurity on ocular structures and visual functions. Arch Dis Child Fetal Neonatal Ed. 2015;100(2):F179–84. https://doi.org/10.1136/archdischild-2014-306207.

Article  PubMed  Google Scholar 

Messa A, Mattos R, Areco K, Sallum J. Vision-related quality of life in children with retinopathy of prematurity. Arq Bras Oftalmol. 2015;78(4):224–8. https://doi.org/10.5935/0004-2749.20150058.

Article  PubMed  Google Scholar 

Palmer E, Flynn J, Hardy R, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 2020;127:S84–96. https://doi.org/10.1016/j.ophtha.2020.01.034.

Article  PubMed  Google Scholar 

Moskowitz A, Hansen R, Fulton A. Retinal, visual, and refractive development in retinopathy of prematurity. Eye Brain. 2016;8:103–11. https://doi.org/10.2147/eb.s95021.

Article  PubMed  PubMed Central  Google Scholar 

Yadav S, Narayan G. Role of ROBO4 signalling in developmental and pathological angiogenesis. Biomed Res Int. 2014;2014: 683025. https://doi.org/10.1155/2014/683025.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dai C, Gong Q, Cheng Y, Su G. Regulatory mechanisms of Robo4 and their effects on angiogenesis. 2019. Biosci Rep. https://doi.org/10.1042/bsr20190513.

Davis C, Zhu W, Gibson C, et al. ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock. J Immunol. 2014;192(12):6045–52. https://doi.org/10.4049/jimmunol.1400309.

Article  PubMed  CAS  Google Scholar 

Pircher A, Wellbrock J, Fiedler W, Heidegger I, Gunsilius E, Hilbe W. New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules. Oncology. 2014;86(1):46–52. https://doi.org/10.1159/000356871.

Article  PubMed  CAS  Google Scholar 

Ishikawa K, Yoshida S, Kadota K, et al. Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2010;51(8):4307–19. https://doi.org/10.1167/iovs.09-4605.

Article  PubMed  Google Scholar 

Jones CA, London NR, Chen H, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med. 2008;14(4):448–53. https://doi.org/10.1038/nm1742.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen S, Zou Y, Song C, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023;118(1):48. https://doi.org/10.1007/s00395-023-01018-w.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao H, Ahirwar D, Oghumu S, et al. Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis. Mol Oncol. 2016;10(2):272–81. https://doi.org/10.1016/j.molonc.2015.10.007.

Article  PubMed  CAS  Google Scholar 

Jones C, Nishiya N, London N, et al. Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol. 2009;11(11):1325–31. https://doi.org/10.1038/ncb1976.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Seo S, Kim M, Kim R, Yeo Y, Kim K, Suh W. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation. Exp Mol Med. 2020;52(10):1744–53. https://doi.org/10.1038/s12276-020-00512-8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hartnett M. Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor. Am J Ophthalmol. 2020;218:208–13. https://doi.org/10.1016/j.ajo.2020.05.025.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Deissler H, Lang G, Lang G. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells. Exp Eye Res. 2014;122:20–31. https://doi.org/10.1016/j.exer.2014.02.024.

Article  PubMed  CAS  Google Scholar 

Gordon E, Fukuhara D, Weström S, et al. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation. Sci Signal. 2016;9(437): ra72. https://doi.org/10.1126/scisignal.aad9256.

Article  PubMed  CAS  Google Scholar 

Papaioannou VE, Fox JG. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci. 1993;43(2):189–92.

PubMed  CAS  Google Scholar 

Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–22. https://doi.org/10.1373/clinchem.2008.112797.

Article  PubMed  CAS  Google Scholar 

Paul J, Coulombe K, Toth P, et al. SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo. J Mol Cell Cardiol. 2013;64:124–31. https://doi.org/10.1016/j.yjmcc.2013.09.005.

Article  PubMed  CAS  Google Scholar 

Bedell V, Yeo S, Park K, et al. roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A. 2005;102(18):6373–8. https://doi.org/10.1073/pnas.0408318102.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abdelsaid M, Coucha M, Hafez S, Yasir A, Johnson M, Ergul A. Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes. Diabetologia. 2017;60(4):740–50. https://doi.org/10.1007/s00125-017-4214-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gong Q, Li F, Xie J, Su G. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy. Endocrine. 2019;65(1):35–45. https://doi.org/10.1007/s12020-019-01921-0.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liao WX, Laurent LC, Agent S, Hodges J, Chen DB. Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia. Biol Reprod. 2012;86(4):111. https://doi.org/10.1095/biolreprod.110.088138.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang F, Prahst C, Mathivet T, et al. The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularization. Nat Commun. 2016;7:13517. https://doi.org/10.1038/ncomms13517.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gao M, Zhao B, Yang W, Tang J, Liu Y. Chidamide inhibits proliferation and promotes apoptosis of esophageal squamous cell carcinoma cells by inhibiting the PI3K/Akt and ERK1/2 pathways and increasing DNA damage. J South Med Univers. 2023;43(11):1926–34. https://doi.org/10.12122/j.issn.1673-4254.2023.11.13.

Article  CAS